前言：目的：探讨血脂康的非调脂功能。
Objective: to study the effect of xuezhikang treating unstable angina pectoris.
结论血脂康与阿托伐他汀降脂疗效与安全性相似。
Conclusion Atorvastatin is similar in curative effect and safety to Xuezhikang.
目的观察血脂康对老年高脂血症的疗效和安全性。
Objective To study the effects and safety of Xuezhikang in elderly patients with hyperlipidemia.
对照组给予口服血脂康胶囊，一次2粒，一日2次。
The former took the TTG orally twice per day with 12g each time.
我们运用血脂康胶囊治疗早期糖尿肾病，取得一定疗效。
We got some efficacies in treating early diabetic nephropathy with Xuezhikang Capsule.
目的：探讨长期服用血脂康对心肌梗死患者颈动脉粥样硬化的影响。
To investigate the longterm effect of Xuezhikang(XZK) on carotid atherosclerosis in patients with myocardial infarction.
目的研究沙棘血脂康对高脂血症大鼠血脂和脂肪肝形成的防治作用。
OBJECTIVE To investigate the preventive role of Hippophae rhamnoides L. Xuezhikang at different concentrations on hyperlipidemia and fatty liver in rats.
目的了解血脂康对2型糖尿病合并高脂血症患者血管内皮细胞的保护作用。
Objective To study the endothelial protective potential of Xuezhikang in type 2 diabetes complicated with hyperlipemia.
血脂康在调脂治疗的同时，可降低FINS及提高ISI，改善胰岛素抵抗。
While regulating blood lipid, Xuezhikang could markedly decrease FINS and increase ISI, as well as relief the insulin resistance.
短期服用血脂康的不良反应主要为胃肠道反应，较少有肝功能异常改变和肌痛。
The adverse reactions of XZK were mainly the gastrointestinal tract reaction, while liver function abnormality and myalgia were scarcely found.
目的探讨脂肪肝患者是否存在胰岛素抵抗（IR），并评价血脂康对其干预效果。
Objective To investigate whether fatty liver disease is associated with insulin resistance(IR), and to evaluate the effect of Xuezhikang intervention for these patients.
给大鼠成模后，随机分为模型组、血脂康组和楂七降脂袋泡茶高、中、低剂量组。
The model rats were divided in-to model group, Zhaqi reduced-fat teabags groups with high, middle and low dosages respective-ly, Xuezhikang group.
目的观察口服血脂康胶囊对老年人冠心病心绞痛并血脂异常患者降脂作用的临床疗效。
Objective to observe the curative effect of oral capsule Xuezhikang on the elder patients with Coronary Heart Disease Angina Pectoris combined by high blood lipid.
血脂康在调脂治疗的同时，可显著降低ET，提高NO、FMD，改善血管内皮功能。
While regulating blood lipid, Xuezhikang could markedly decrease ET and increase NO, FMD, as well as improve the endothelial function.
降脂冲剂组及血脂康组大鼠仅在动脉分叉处见到少量斑块，病变较轻，呈散在斑点状。
A few plaques could be seen only at the artery crotch of rats in Jiangzhi Granule group and Xuezhikang group, and distributed as diffusing mottling, which indicated light pathological changes.
目的总结多中心临床试验“血脂康调整血脂对冠心病的二级预防研究”中血清总胆固醇（TC）和甘油三酯（TG）测定室间质量控制结果。
Objective To summarize the external quality control results on the measurement of TC and TG for a multi-center clinical trial.
结论：地赐康是一种有效的血脂调节剂，且依从性好，服用安全。
Conclusion:Dicikang is an effective lipid regulator and has a good compliance and reliability.
目的研究益脂康对内源性和外源性家兔高血脂模型的降血脂作用。
OBJECTIVE To study the effect of Yizhikang on lowering blood lipids of endogenous and exogenous hyperlipidemia model in rabbits.
目的：探讨糖康明胶囊对糖尿病大鼠血糖、血脂及血液流变性的影响。
Objective: To study the effects of Tangkangming capsule on blood glucose, blood lipids and hemorrheology in diabetic rats.
模型组大鼠血脂、ALT较空白对照组和肝脂康组显著增高（P＜0.01）；
The blood-fat and ALT of the rats in the model group increased markedly compared with the blank control group (P<0.01);
模型组大鼠血脂、ALT较空白对照组和肝脂康组显著增高（P＜0.01）；
The blood-fat and ALT of the rats in the model group increased markedly compared with the blank control group (P<0.01);
应用推荐